Loading
companiesCompany
SageMedic
SageMedic builds 3D microtumours from a patient's solid tumour and measures how candidate drugs and combinations kill or slow them, including for rare cancers and cancers of unknown primary.
Overview
SageMedic's SAGE Oncotest provides functional drug response testing and tissue evaluation for solid tumours using 3D microtumours to assess tumour cell killing, growth inhibition and drug combination activity. Based in Redwood City, California; physician-ordered.
Similar pages
- Company2cureX
Shares Functional (ex vivo) drug testing, Patient-derived organoids and the tag fcct-directory.
- CompanyCure-First
Shares Functional (ex vivo) drug testing, Patient-derived organoids and the tag fcct-directory.
- CompanySpeciCare
Shares Functional (ex vivo) drug testing, Patient-derived organoids and the tag fcct-directory.
- CompanyTravera
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanyKiyatec
Shares Functional (ex vivo) drug testing, Patient-derived organoids and the tag fcct-directory.
- CompanyFirst Ascent Biomedical
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanyKYAN Technologies
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanyStoreMyTumor
Shares Functional (ex vivo) drug testing and the tag fcct-directory.